Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Medpace (MEDP)

Nasdaq Health Care Life Sciences Tools & Services S&P MidCap 400
$653.11
+18.13 (+2.86%)
Close of Nov 06, 2026 · end-of-day data
Source: Medpace's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$421.58M$436.15M$704.59M$860.97M$925.92M$1.14B$1.46B$1.89B$2.11B$2.53B
Selling, general & admin$61.51M$63.36M$75.68M$95.25M$92.16M$108.42M$131.40M$161.35M$180.18M$197.56M
Operating income$52.49M$64.86M$101.05M$127.26M$167.04M$198.62M$278.70M$336.82M$446.87M$534.93M
Pre-tax income$21.96M$56.95M$93.95M$124.83M$168.53M$201.85M$282.86M$335.68M$475.92M$542.38M
Income tax$8.53M$17.82M$20.77M$24.39M$23.15M$20.00M$37.49M$52.87M$71.54M$91.25M
Net income$13.43M$39.12M$73.19M$100.44M$145.38M$181.85M$245.37M$282.81M$404.39M$451.12M
EBITDA$59.93M$73.43M$110.29M$135.62M$178.69M$214.62M$297.69M$360.95M$474.68M$562.11M
EPS (basic)$0.38$1.00$2.05$2.79$4.07$5.06$7.57$9.20$13.06$15.64
EPS (diluted)$0.37$0.98$1.97$2.67$3.84$4.81$7.28$8.88$12.63$15.28
Diluted shares36.33M39.84M36.91M37.58M37.71M37.70M33.67M31.84M32.01M29.53M
Operating margin12.5%14.9%14.3%14.8%18.0%17.4%19.1%17.9%21.2%21.1%
Net margin3.2%9.0%10.4%11.7%15.7%15.9%16.8%15.0%19.2%17.8%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$37.10M$26.48M$23.27M$131.92M$277.77M$461.30M$28.27M$245.45M$669.44M$497.05M
Receivables$79.77M$83.08M$133.45M$155.66M$160.96M$186.43M$253.40M$298.40M$296.44M$402.08M
Total current assets$133.25M$129.97M$178.11M$317.03M$473.65M$690.91M$333.96M$593.83M$1.03B$989.62M
Goodwill$660.98M$660.98M$660.98M$662.40M$662.40M$662.40M$662.40M$662.40M$662.40M$662.40M
Total assets$979.11M$950.72M$967.93M$1.14B$1.39B$1.66B$1.35B$1.66B$2.10B$1.98B
Total current liabilities$168.60M$192.71M$257.03M$343.00M$440.11M$557.22M$803.47M$925.13M$1.10B$1.34B
Short-term debt$12.38M$16.50M$0——$0$50.00M$0——
Long-term debt$151.27M$205.11M$79.72M$0——————
Total debt$163.64M$221.61M$79.72M$0—$0$50.00M$0——
Total liabilities$368.39M$447.19M$378.23M$416.79M$584.90M$707.01M$966.11M$1.10B$1.28B$1.52B
Shareholders' equity$610.71M$509.26M$598.86M$726.28M$805.78M$952.93M$386.39M$558.95M$825.54M$459.07M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$91.73M$97.39M$156.58M$201.87M$258.68M$263.33M$388.05M$433.37M$608.82M$713.22M
Capital expenditures$13.54M$11.72M$16.02M$17.91M$31.34M$28.27M$36.88M$36.65M$36.55M$31.36M
Free cash flow$78.19M$85.66M$140.56M$183.96M$227.34M$235.06M$351.17M$396.73M$572.27M$681.87M
Investing cash flow-$13.42M-$12.24M-$16.97M-$19.14M-$31.21M-$31.36M-$38.74M-$34.63M-$28.31M-$31.14M
Financing cash flow-$58.01M-$97.83M-$141.58M-$73.92M-$82.28M-$44.45M-$775.77M-$182.64M-$154.01M-$860.39M
Share buybacks$0$155.58M$0$0$98.27M$62.10M$847.85M$144.02M$169.87M$917.39M
Stock-based compensation$9.81M$4.46M$6.50M$20.74M$13.78M$14.47M$21.41M$20.52M$25.51M$34.79M
Depreciation & amortization$7.44M$8.57M$9.24M$8.36M$11.65M$16.00M$18.99M$24.13M$27.81M$27.18M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.